Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review
Abstract Introduction Etanercept (ETN), a highly effective biological agent for the treatment of psoriasis (PSO) and psoriatic arthritis (PsA), is widely used in Spain. However, evidence of its economic impact is limited, indicating the need for a systematic review of the economic assessments conduc...
Saved in:
Main Authors: | Lluís Puig (Author), Lourdes Rodríguez Fernández-Freire (Author), Ramón Burgos-Pol (Author), Ismael Gomez (Author), Carmen Peral (Author), Susana Gomez (Author), Francisco José Rebollo Laserna (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020) -
Etanercept-Induced Hypoglycemia in a Patient With Psoriatic Arthritis and Diabetes
by: Emily C. Pfeifer MD, et al.
Published: (2017) -
Genetics of psoriasis and psoriatic arthritis
by: Chandran Vinod
Published: (2010) -
GENETICS OF PSORIASIS AND PSORIATIC ARTHRITIS
by: V. Ibba, et al.
Published: (2011) -
EPIDEMIOLOGY OF PSORIASIS AND PSORIATIC ARTHRITIS
by: M.A. Cimmino
Published: (2011)